VistaGen TherapeuticsVTGN 
$3.700.82%24h
0.82%24h
Global rank21366
Market cap$25.75M
Change 7d3.35%
YTD Performance-26.73%
SP500 benchmarkUnderperform
P/E-0.43
P/S-113.29
Revenue-$227.30K
Earnings-$59.25M
Dividend yield-
Main Sector
Healthcare
Category
VistaGen Therapeutics VTGN Operating Margins
Operating Margin in 2022: 260.75%
According to VistaGen Therapeutics latest financial reports the company has an operating margin of 260.75%, an decrease of -708.13% to 2022. At the end of 2022 company had an operating margin of -42.88%.
VistaGen Therapeutics Operating Margin from 2021 to 2024
-
Value:-
VTGN Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 260.75% | -708.13% |
| 2022 | -42.88% | 160.48% |
| 2021 | -16.46% | - |
View the highest operating margin companies 
